Cubist Pharmaceuticals, Inc. (CBST) Tops Q2 EPS by 23c

July 19, 2012 4:07 PM EDT Send to a Friend
Cubist Pharmaceuticals, Inc. (NASDAQ: CBST) reported Q2 EPS of $0.68, $0.23 better than the analyst estimate of $0.45. Revenue for the quarter came in at $230.6 million versus the consensus estimate of $226.05 million.

For earnings history and earnings-related data on Cubist Pharmaceuticals, Inc. (CBST) click here.

Serious News for Serious Traders! Try Premium Free!

You May Also Be Interested In

Related Categories

Earnings, Hot Earnings

Related Entities


Add Your Comment